Corcept Therapeutics logo

Corcept Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States501-1000 Employees

Corcept Therapeutics is a biotechnology company focused on cortisol modulation, developing molecules that regulate cortisol activity at the glucocorticoid receptor. Over more than 25 years, the company has identified and advanced more than 1,000 selective proprietary cortisol modulators. In 2012, it achieved FDA approval of a cortisol receptor blocker—the first approved treatment for Cushing's syndrome. Today, the organization is pursuing more than 30 ongoing studies across endocrinology, oncology, metabolism, and neurology to explore the broader therapeutic potential of cortisol modulation. Based in Redwood City, California, the company operates within the biotechnology research sector, focusing on cortisol signaling as a basis for treating serious diseases. In 2026, Corcept announced plans to present new data from the pivotal ROSELLA Phase 3 trial of Lifyorli for platinum-resistant ovarian cancer at ASCO 2026.

Find Corcept Therapeutics employees' phone numbers or email addresses

Corcept Therapeutics Global Highlights

Location
Employees

North America
813

Minus sign iconPlus sign icon
  • United States Of America
    813

Europe
17

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    14
  • Ireland
    1
  • Switzerland
    1
  • Netherlands
    1

Africa
1

Minus sign iconPlus sign icon
  • Egypt
    1

Asia
1

Minus sign iconPlus sign icon
  • United Arab Emirates
    1

Corcept Therapeutics's Leadership

  • Chief Scientific Officer at Corcept Therapeutics
    H. H.
    Chief Scientific Officer
  • Chief Development Officer at Corcept Therapeutics
    W. G.
    Chief Development Officer
  • Chief Development Officer (cdo) at Corcept Therapeutics
    W. B.
    Chief Development Officer (cdo)
  • Vice President Of Manufacturing at Corcept Therapeutics
    Y. C.
    Vice President Of Manufacturing
  • Head Of Oncology And Neurology Clinical Development at Corcept Therapeutics
    A. J.
    Head Of Oncology And Neurology Clinical Development
  • Head Of Legal And Compliance, Europe at Corcept Therapeutics
    R. M.
    Head Of Legal And Compliance, Europe
  • Vice President, Marketing at Corcept Therapeutics
    J. P. H.
    Vice President, Marketing
  • Vice President, Head Of Biometrics at Corcept Therapeutics
    I. C. T.
    Vice President, Head Of Biometrics

Corcept Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Sales
  • Operations
  • Engineering
  • Quality Assurance
  • Accounting
  • Other
  • Research
  • Marketing
  • Administrative
  • Legal
  • Biotechnology

Contact profiles from Corcept Therapeutics

Name
Title
Contact
Location
Last Update
  • Associate Director, Quality Systems Technology at Corcept Therapeutics
    W. H.
    Associate Director, Quality Systems Technology
    Bay
    Jul 09, 2026
  • Associate Director, Clinical Records (tmf) at Corcept Therapeutics
    A. B.
    Associate Director, Clinical Records (tmf)
    Bay
    Aug 03, 2026
  • Senior Director, Chemical Development at Corcept Therapeutics
    G. R.
    Senior Director, Chemical Development
    United Kingdom, England
    Aug 26, 2026
  • Director Health Economics at Corcept Therapeutics
    G. S.
    Director Health Economics
    United Kingdom
    Mar 24, 2026
  • Associate Director, Commercial Analytics at Corcept Therapeutics
    J. B.
    Associate Director, Commercial Analytics
    Bay
    Jun 27, 2026
  • Associate Director, Formulations at Corcept Therapeutics
    J. W.
    Associate Director, Formulations
    Bay
    Jul 01, 2026
  • Senior Director, Intellectual Property at Corcept Therapeutics
    L. Y.
    Senior Director, Intellectual Property
    Bay
    Jun 28, 2026
  • Associate Director, Sales Analytics & Operations at Corcept Therapeutics
    L. P.
    Associate Director, Sales Analytics & Operations
    Bay
    Aug 31, 2026
  • Associate Director, People Technology at Corcept Therapeutics
    M. W.
    Associate Director, People Technology
    Bay
    Sep 04, 2026
  • Marketing Director Eu (ad Interim) at Corcept Therapeutics
    M. G.
    Marketing Director Eu (ad Interim)
    United Kingdom, England
    Aug 24, 2026

Frequently Asked Questions

What is Corcept Therapeutics known for?

Minus sign iconPlus sign icon
Corcept Therapeutics was founded in 1998 and operates in the Biotechnology Research industry. You can contact Corcept Therapeutics's main corporate office by phone at . Explore Corcept Therapeutics's company overview page for more information.

What is Corcept Therapeutics's most common email format?

Minus sign iconPlus sign icon
Corcept Therapeutics employees' email format typically follows the pattern of FLast@corcept.com. Trying to find reliable and up-to-date employee contact data? Find more Corcept Therapeutics email formats with LeadIQ.

How many employees does Corcept Therapeutics have currently?

Minus sign iconPlus sign icon
Corcept Therapeutics has approximately 790 employees as of August 2026. These team members are located across 4 continents, including North America, Europe and Africa.

Who are Corcept Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Corcept Therapeutics's key employees include:

  • Chief Scientific Officer: H. H.
  • Chief Development Officer: W. G.
  • Chief Development Officer (cdo): W. B.
  • Vice President Of Manufacturing: Y. C.
  • Head Of Oncology And Neurology Clinical Development: A. J.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.